(Q46910754)

26 December 2017

title

Effects of psychotropics on glycosylated hemoglobin (HbA1c) in a cohort of bipolar patients (English)

1 reference

26 December 2017

1 reference

1 reference

glycosylated hemoglobin

23 October 2023

Ruby Castilla-Puentes

series ordinal

1

1 reference

26 December 2017

publication date

1 November 2007

1 reference

26 December 2017

published in

Bipolar Disorders

1 reference

26 December 2017

volume

9

1 reference

26 December 2017

issue

7

1 reference

26 December 2017

page(s)

772-778

1 reference

26 December 2017

Atypical antipsychotics and diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00534.X

Antipsychotic-induced type 2 diabetes: evidence from a large health plan database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00534.X

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00534.X

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00534.X

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00534.X

The use of claims databases for outcomes research: rationale, challenges, and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00534.X

The natural history of type 2 diabetes. Implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00534.X

Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2007.00534.X

Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1399-5618.2007.00534.X

Impact of insulin lispro on HbA1c values in insulin pump users

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1399-5618.2007.00534.X

The effects of novel antipsychotics on glucose and lipid levels.

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1399-5618.2007.00534.X

Atypical antipsychotics and mood stabilization in bipolar disorder

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1399-5618.2007.00534.X

The treatment of thalassemia--slow progress and new dilemmas

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1399-5618.2007.00534.X

Clinical features of bipolar disorder with and without comorbid diabetes mellitus

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1399-5618.2007.00534.X

Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1399-5618.2007.00534.X

Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1399-5618.2007.00534.X

Identifiers

DOI

10.1111/J.1399-5618.2007.00534.X

1 reference

26 December 2017

1 reference

26 December 2017